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Abstract 
Objective: The literature is inconclusive regarding predictors of treatment outcome in 
obsessive-compulsive disorder (OCD). Illness perception (IP) has been identified as an 
important predictor of treatment outcome in somatic and mental health, but has not 
previously been investigated in OCD patients. The aims of the present study were to 
investigate variables related to IP pre-treatment and to explore whether IP could predict 
treatment outcome. Method: A total of 76 patients were assessed with the Brief Illness 
Perception Questionnaire (B-IPQ), Y-BOCS and BDI. The OCD patients` IP was  
compared to reference-groups of patients with rheumatoid arthritis (RA) and bipolar 
disorder (BD). Results: The OCD-sample expressed generally severe illness 
perceptions, and in some aspects more severe compared to patients with RA and BD. 
OCD severity explained 18 % of pre-treatment IP variance. After treatment, significant 
positive changes in IP was seen. The B-IPQ dimension coherence explained 6 % of 
OCD severity post-treatment. Conclusion: The results indicate that B-IPQ is a useful 
instrument for capturing OCD patients` perceptions of disorder-specific symptoms, as 
well as a sensitive instrument for relatively rapid changes in OCD symptoms. However, 
only the perceptual dimension coherence was related to treatment outcome. Clinical and 
research implications are discussed.  
 
Keywords: OCD, illness perception, the B-IPQ 
 
 
 
 
Illness perception in treatment seeking OCD patients 6	  
Sammendrag 
Målsetting: Flere studier har undersøkt prediktorer for behandlingsutfall hos pasienter 
med tvangslidelse (OCD) uten konkluderende resultater. Sykdomsoppfatning (Illness 
perception; IP) er identifisert som en viktig prediktor for behandlingsutfall i somatisk og 
psykisk helse, men har ikke tidligere blitt undersøkt hos pasienter med OCD. Målene 
med dette studiet var å undersøke variabler relater til IP før behandling, og å undersøke 
om IP kunne bidra til å predikere behandlingsutfall. Metode: Totalt 76  
pasienter ble vurdert med Brief Illness Perception Questionnaire (B-IPQ), Y-BOCS og 
BDI. OCD pasientenes sykdomsoppfatning ble sammenlignet med pasienter med  
reumatoid artritt (RA) og bipolar lidelse (BD). Resultater: OCD utvalget oppfattet 
lidelsen sin som alvorlig, og i noen tilfeller mer alvorlig sammenlignet med 
referanseutvalg. OCD alvorlighetsgrad bidro til å forklare 18 % av variansen i generell 
sykdomsoppfatning før behandling. Det var signifikante positive endringer i 
sykdomsoppfatning etter behandling. B-IPQ dimensjonen coherence forklarte 6 % av 
variansen i OCD alvorlighetsgrad etter behandling. Konklusjon: Resultatene indikerer 
at B-IPQ er et hensiktsmessig instrument for å tilnærme seg OCD pasienters 
sykdomsforståelse i henhold til sykdomsspesifikke symptomer, i tillegg til å være et 
sensitivt instrument for relative raske endringer i OCD symptomer. Coherence var 
derimot den eneste dimensjonen som var relatert til behandlingsutfall. Implikasjoner for 
klinikk og forskning blir diskutert. 
 
Nøkkelord: OCD, sykdomsoppfatning, B-IPQ 
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Introduction 
Obsessive-compulsive disorder (OCD) is characterized by intrusive thoughts or 
images (obsessions) that lead to increased anxiety or discomfort, followed by 
intentional repetitive behavior (compulsions) aimed at anxiety reduction (American 
Psychiatric Association 2000, Abramowitz 1997). The World Health Organization has 
ranked the condition as one of the ten most debilitating illnesses (WHO 2001), and it is 
reported to be the fourth most common psychiatric diagnosis (Jenike 2001). Untreated, 
OCD tends to become chronic (Kessler et al. 2005). OCD has high comorbidity with a 
range of other disorders, among those depression and other anxiety disorders (Ruscio et 
al. 2010). 
Cognitive-Behavioral Therapy (CBT) using Exposure- and Response-Prevention 
(ERP) is often considered the psychological treatment of choice for OCD, and is 
recognized as an effective and efficient approach (Abramowitz 1997, Öst et al. 2015). 
ERP has been proven effective when delivered in a range of different formats 
(Abramowitz 1996, Öst et al. 2015). A recent meta-analysis of all randomized-
controlled trials on CBT for OCD published between 1993 and 2015 (Öst et al. 2015), 
applying Jacobson and Truax (1991) criteria for clinical significant change (CSC), 
showed proportions CSC varying from 43-52% following CBT. These results thus 
indicates that a large number of patients do not have satisfactory outcome.  
Pampaloni et al. (2004) found that gender, duration, insight, severity, 
comorbidity, tics, side effects, previous treatment, drugs/challenge all were variables 
that influenced outcome. However, in the most recent meta-analysis to date (Öst et al. 
2015), only the predictors gender, age, concurrent antidepressant medication and 
proportion of patients declining treatment were related to treatment outcome. Further, in 
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an earlier meta-analysis by Olatunji et al. (2013) only age was found to influence 
treatment outcome, and Rosa-Alcázar et al. (2008) found that only comorbidity 
contributed to treatment outcome. These results make it difficult to draw firm 
conclusions concerning treatment predictors.  
From an extensive literature on the relationship between individual 
characteristics and treatment response in somatic conditions, we know that illness 
perception or the way patients understand their illness, has significant impact on illness 
coping strategies, treatment adherence and medication adherence (e.g. Hagger and 
Orbell 2003, Brown et al. 2001, Kucukarslan 2012). Illness perception, defined as the 
organized cognitive representations that patients have about their illness (Petrie et al. 
2007), is identified as of importance also in mental disorders, but has to our knowledge, 
not previously been investigated as a possible predictor of treatment response in OCD 
patients. Previous research indicates that patients with mental disorders commonly have 
negative perceptions about chronicity and severity of the illness, and that negative 
illness perception influences health seeking behavior as well as the way they utilize care 
(Baines and Wittkowski 2013).  
In the work of identifying patients` illness perception the Self-Regulation Model 
(SRM) has frequently been used as a framework for describing the perceptions people 
have about their health condition (Leventhal et al. 1984). This self-regulatory social 
cognition model has been extensively studied in physical illnesses, but has only recently 
started to receive attention in the study of mental disorders as well (Broadbent et al. 
2008). The SRM proposes that individuals create common-sense beliefs regarding their 
illness, and that these beliefs are important for understanding and coping when faced 
with health threat (Petrie et al. 2008). Based on the principle of self-regulation the 
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model also proposes that people are active problem solvers who use emotional and 
cognitive illness perceptions to find solutions and adapt coping behavior accordingly 
(Leventhal et al. 1984). This is claimed to be a dynamic process where changes in 
symptoms or new information may lead to re-evaluation of the patients` perceptions of 
their illness and by this also a shift in coping behavior, help-seeking strategies or 
emotional response (Petrie et al. 2008, Baines and Wittkowski 2013). It has therefore 
been argued that trying to understand patients` illness perception and encourage health 
professionals in making treatment interventions more person-centered, is of importance 
regarding treatment acceptance, response and outcome (Williams and Steer 2011, 
Weinman and Petrie 1997). Individually tailored treatment could also be argued as of 
importance in a stepped-care perspective where identification of pre-treatment factors 
influencing treatment outcome, may be of importance in refining the ERP-based 
treatment to make the treatment more effective (Gilliam et al. 2010).  
The SRM suggests that there is a consistent pattern in patients` illness perception 
and five distinct dimensions have been identified: identity, timeline, consequences, 
cause and cure/control (Leventhal et al. 1984). These dimensions have received 
empirical support from later research (Petrie et al. 2008). Identity includes the name of 
the illness and the range of symptoms that the patients perceive as associated with the 
condition. Timeline contain the patients` perception of how long the illness will last. 
Consequences assess the patients` perception of what kind of consequences the illness 
will have for their lives. Cause assesses what the patients` perceive as the cause of their 
illness, and cure/control the patients` perception of personal control of the illness and to 
what extent the illness can be influenced by treatment (Leventhal et al. 1980).  
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The five dimensions in illness perception are seen as interrelated. If illness is 
perceived as having severe consequences, it is likely that the illness also is perceived as 
having a longer timeline as well as negative perceptions related to treatment as helpful 
(Petrie et al. 2008). On the one hand, illness perception is a framework addressing 
illness symptomology, but on the other hand illness perception is also contributing to a 
description of the variance within the different illnesses. The variability of illness 
perception between patients with similar conditions, have been discussed as one of the 
most interesting aspects regarding illness perception and adds to the principle of 
individually tailored treatment as a way to assess and assist patients in their adjustment 
to illness and recovery (Petrie et al. 2008). 
To assess illness perception the Illness perception questionnaire (IPQ) was 
developed based on the SRM model and the five perceptual dimensions (Weinman et al. 
1996). The IPQ was later revised (IPQ-R; Moss-Morris et al. 2002), and the revised 
version has been adapted to a short form (the Brief Illness Perception Questionnaire; B-
IPQ; Broadbent et al. 2006).  In the B-IPQ the original five dimensions in the SRM-
model has been revised and expanded, and the eight dimensions in the B-IPQ consists 
of: consequences (item 1), which assesses the perceived effect of the illness on the 
patient`s life. Timeline (item 2) assesses perceptions of how long the illness will last. 
Personal control (item 3) assesses how the patient` own behavior can influence the 
course of the illness, and treatment control (item 4) perceptions about available 
treatment. Identity (item 5) assesses perceived symptoms, and concern (item 6) 
concerns about the illness. Coherence (item 7) assesses how well patients believe they 
understand their illness and emotional representations (item 8) the perceived emotional 
influence on the patients` life (Broadbent et al. 2006). In addition there is an open-ended 
Illness perception in treatment seeking OCD patients 11	  
question assessing perceived causal factors of the illness. The psychometric properties 
of the B-IPQ is reported to be good (Petrie et al. 2007). The B-IPQ has made possible a 
rapid assessment of illness perception compared to the IPQ or IPQ-R, and has by this 
offered the potential for investigating illness perception in a wider range of patients 
groups, using repeated measures or when illness perceptions are measured as part of a 
larger self-report battery (Broadbent et al. 2006). 
In the present study the illness perception in two consecutive samples of OCD 
patients undergoing ERP treatment delivered during 4 consecutive days (Havnen et al. 
2013, Havnen et al. 2014, Havnen et al. 2015), will be described using the dimensions 
in the B-IPQ. Since the intervention is highly concentrated, it might be argued that it is 
exceptionally suitable for studying the relationship between illness perception and 
treatment outcome with limited interference from treatment irrelevant factors or 
processes that usually run in parallel with the treatment and which might influence the 
outcome (e.g. life events, minor relapses, set-backs etc.). The format has been described 
as individual treatment in a group setting, in which each treatment group consists of 5-6 
patients, and the ratio between patients and therapists are 1:1. During the 4-day 
intervention, the first day, lasting four hours, is allocated to psychoeducation to ensure 
that each patient understands and complies with the treatment principles, and to plan 
and specify individually tailored exposure tasks.  
During the psychoeducation a number of disorder relevant aspects are covered, 
such as causes for OCD; heritability and individual vulnerability; precipitating and 
maintaining factors; personal control over the treatment outcome; typical mistakes 
during exposure training and the importance of response prevention; as well as 
information about the evidence-based treatment. At the end of the psychoeducation each 
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patient present suggestions for exposure tasks, and get feed-back to ensure that they 
cover all individually relevant domains.  
Day 2 and day 3, each lasting approximately eight hours, are dedicated to 
therapist assisted exposure treatment in a variety of relevant settings. The last day is 
used for summarizing the treatment (“lessons learnt”) and to plan the next three weeks 
of daily exposures that the patient will do on their own. The 4-day format is highly 
efficient and there is basically no drop-out. Also, the patients express a high degree of 
satisfaction with the approach (Havnen et al. 2014).  
Since there is no previous research on OCD and illness perception, it is of 
interest to compare illness perception in OCD patients to illness perception in other 
chronic, but not life threatening, somatic as well as psychiatric disorders. As reference 
populations we have selected one group of patients with a chronic somatic disorder, 
rheumatoid arthritis (RA), and one group of patients with a severe mental disorder, 
bipolar disorder (BD). Severity of illness in patients with RA is especially associated 
with perceived negative consequences and less personal control of their illness (Rezaei 
et al. 2014), while in patients with BD negative perceptions regarding consequences, 
identity and personal control, have been associated with increased relapse-rates, and 
likelihood of greater fluctuations of depressed mood (Lobban et al. 2013). Thus, the 
aims of the current paper were: 
1. To assess illness perceptions in a large sample of treatment seeking OCD 
patients, using patients with RA and BD as reference samples. Based on the 
diagnostic characteristics of the disorder, we expected that the OCD patients 
perceived their illness as quite severe with major consequences and negative 
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emotional impact on their lives as well as reduced personal control and a 
long illness timeline. 
2. To explore to what extent pre-treatment illness perception were related to 
OCD severity, symptoms of depression, OCD duration, gender, age, use of 
SSRI, comorbidity and previous treatment experiences. We expected that 
higher OCD severity was associated with more negative perceptions on the 
B-IPQ dimensions.  
3. To investigate the relationship between pre-treatment illness perceptions and 
treatment outcome after a 4-day intensive ERP-based group intervention. 
Based on previous findings in other somatic and mental disorders where 
illness perception has been associated with treatment outcome, we expected 
pre-treatment illness perception to be associated with treatment outcome.  
4. To investigate possible changes in illness perceptions from pre-to post-
treatment. Since the 4-day format is associated with substantial clinical 
improvement we expected significant changes in illness perception after the 
intervention. 
Methods 
Referral procedures, diagnostics and pre-treatment measurements.  
All patients were referred to the OCD-clinic at Haukeland University Hospital, 
which is an outpatient unit part of the specialist health care. All adult patients in the 
Helse Bergen catchment area of 420.000 inhabitants, with potential OCD, are referred 
to this clinic. Prior to the first session all referred patients completed a standard battery 
of self-report questionnaires including the Beck Depression Inventory (BDI; Beck et al. 
1996) and the Brief Illness Perception Questionnaire (B-IPQ; Broadbent et al. 2006). 
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Patients then met for an initial screening session during which the Norwegian version of 
Mini International Neuropsychiatric Interview (MINI; Leiknes et al. 2005) was 
administered to ensure a diagnosis of OCD (American Psychological Association 
2000). Patients who met diagnostic criteria for OCD were then interviewed with the 
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS; Goodman et al. 1989). The B-IPQ 
and Y-BOCS were administered before and after treatment. MINI and Y-BOCS 
interviews were conducted by trained clinical psychologists or a psychiatrist. 
Post-treatment measurements 
Post-treatment the patients were interviewed with the clinician administered Y-
BOCS and completed the standard post-treatment self-report assessment which included 
the B-IPQ. The primary outcome measure was change in the Y-BOCS score and the B-
IPQ dimensions from pre-treatment to one week post-treatment.  
Measures 
The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS; Goodman et al. 1989) 
was used to measure severity of obsessive-compulsive symptoms. The Y-BOCS 
consists of 10 items of which 5 cover the severity of obsessions and 5 cover the severity 
compulsions. Each item is rated from 0-4, total score range is 0-40 with higher scoring 
indicating higher degree of severity. The total score can be categorized as sub-clinical 
(0-7), mild (8-15), moderate (16-23), severe (24-31), and extreme (32-40). The Y-
BOCS has good psychometric properties with reported Cronbach`s α ranging from 0.88 
to 0.91 (Goodman et al. 1989). Cronbach`s α in the present sample was 0.74.  
 The Beck Depression Inventory (BDI; Beck et al. 1996) was used to assess 
symptoms of depression. BDI has 21 items which are rated on a 0-3 scale, where higher 
total score indicate more severe symptoms of depression, with a maximum total score of 
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63. The total score can be categorized as minimal (0-13), mild (14-19), moderate (20-
24) and severe (>25) depression. The psychometric properties of BDI are well 
established (Beck and Steer 1984). Cronbach`s α in this sample was 0.886.  
The Brief Illness Perception Questionnaire (B-IPQ; Broadbent et al. 2006, 
appendix 1) was used to assess illness perceptions. The B-IPQ is a nine-item 
questionnaire. The first eight items each assesses one dimension of illness perception; 
(1) consequences, (2) timeline, (3) personal control, (4) treatment control, (5) identity, 
(6) concern, (7) coherence and (8) emotional representation. The ninth item is an open 
ended question about the perceived cause of the illness where the respondents are to list 
the three most important factors they believe cause their illness (Broadbent et al. 2006). 
Due to limited responses this item was not analyzed in the present study.  
The items are rated on a 0-10 Likert scale. The Likert scale indicates perceived 
severity of illness experience. In the current questionnaire the term illness was replaced 
with obsessive-compulsive disorder to specifically measure OCD and no other illnesses. 
The overall score for items 1-8 gives a scoring range of 0-80. When calculating the total 
score, items 3, 4 and 7 are reversed. The greater the score, the more severe the 
participant perceive their illness to be. Higher responses on the items 1, 2, 5, 6, and 8 
represent more negative illness perceptions and higher scores on the items 3, 4, and 7 
indicate more positive perceptions. In the present study the B-IPQ items were also 
analyzed separately and in these analysis the items 3, 4 and 7 were not reversed. The B-
IPQ has demonstrated good test–re-test reliability and validity in previous research 
(Petrie et al. 2007, Broadbent et al. 2006). Cronbach`s α in the present sample was 0.50.  
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Sample characteristics 
The current study is based on 76 patients (69.7 % female) from two consecutive 
samples, one with 35 patients (Havnen et al. 2014), and one with 41 patients described 
in Havnen et al. 2015. All patients took part in a 4-day concentrated group ERP 
treatment for OCD. For more detailed description of the treatment, see Havnen et al. 
(2013) and Havnen et al. (2014). 
Age ranged from 18 to 69 years with a mean age of 32.11 (SD = 10.5). The self-
reported length of the OCD was from 1 year up to 41 years and with a mean duration of 
15.76 years (SD = 10.48). When referred to the clinic 40 (52.6 %) patients reported 
receiving pharmacological treatment prior to treatment. Of these, 31 (40.8 %) patients 
reported using SSRI. Y-BOCS-rated severity of OCD symptoms showed a mean sample 
score of 25.80 (SD = 4.23). The mean sub-scores for obsessions were 13.13 (SD = 2.17) 
and for compulsions 12.89 (SD = 2.48). In the present sample 71.1 % (n = 54) were 
classified with severe/extreme OCD (Y-BOCS 24-40), and 28.9 % (n = 22) were 
classified with moderate OCD (Y-BOCS 16-23).  
Severity of depression measured with the BDI showed a sample mean score of 
17.45 (SD = 9.1). A total of 23.7 % (n = 18) of the patients had BDI scores indicating 
severe depression (BDI > 25) prior to treatment. Further, 32.9 % (n = 25) had BDI 
scores indicating moderate depression (BDI 15-24), and 21.1 % (n = 16) had a BDI 
score indicating mild depression (BDI 10-14). A total of 17.1 % (n = 13) had BDI 
scores indicating minimal symptoms of depression (BDI 0-9). A total of 60.5 % (n = 
46) had one or more comorbid diagnoses, mainly including other anxiety disorders and 
depression. 
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Improvement in OCD symptoms after treatment 
Y-BOCS rated severity of OCD symptoms showed a sample mean score of 
10.08 (SD = 4.38). Post-treatment severity of depression measured with the BDI 
showed a sample mean score of 11.01 (SD = 7.19). Applying the criteria for clinical 
significant change, used by Fisher and Wells (2005), 77 % of the patients in the sample 
were classified as recovered and 9.5 % as improved (Havnen et al. 2014, Havnen et al. 
2015).  
Previous psychological and pharmacological treatment 
The patients were initially asked to report if they previously had received 
treatment or if they had not. A total of 82.9 % (n = 63) reported that they previously had 
received one or more treatments, including either psychological or pharmacological 
treatment, or both. Further, 5.3 % (n = 4) reported that they had not previously received 
psychological or pharmacological treatment, and 11.8 % (n = 9) had missing data 
regarding previous treatment.  
Reference samples 
Reumatoid arthritis: Rezaei et al. (2014) examined the role of illness 
perceptions in the relationship between depression and experienced pain in rheumatoid 
arthritis (RA). The patients were recruited from an outpatient rheumatology clinic 
affiliated with Isfahan University of Medical Sciences in Iran, during 2011 and 2012. 
The sample consisted of 100 patients, 72 females, with a mean age of 45.46 (SD = 
12.67) and 28 males with a mean age of 40.68 (SD = 13.99). Disease duration ranged 
between 6 months and 26 years with a mean of 5.67 (SD = 5.74) years. Illness 
perceptions were measured using the B-IPQ.  
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Bipolar disorder: Lobban et al. (2013) explored the impact of illness perception 
on symptomatic outcome in bipolar disorder (BD). The sample consisted of 91 patients 
diagnosed with bipolar 1 or 2, with risk of future relapse. The patients were recruited 
from community mental health teams in England, UK. The sample consisted of 61 (67 
%) female with mean age 45 (SD = 10.0) years. Mean duration of illness was 21 (SD = 
12.0) years. Illness perceptions were measured using the B-IPQ modified for BD.  
Statistical analyses 
Statistical analyses were conducted in SPSS version 22. Data were analyzed 
using descriptive analysis, correlational analysis, independent and paired t-tests and 
stepwise multiple regression analyses. Independent t-tests were conducted to investigate 
the possible differences between the OCD patients and the two reference-groups BD 
and RA. An explorative correlational analysis was conducted to investigate the 
relationships between the dimensions in the B-IPQ, demographic variables and clinical 
aspects of OCD. Stepwise multiple regression analyses were then conducted to identify 
possible predictors of illness perception in the OCD patients prior to the 4-day 
intervention, with the B-IPQ total score and all the eight B-IPQ dimensions pre-
treatment separately analyzed as the dependent variable. Paired t-tests were conducted 
to investigate changes in relevant variables from pre- to post-treatment. Also, a stepwise 
multiple regression analysis was conducted to test the influence of potential predictors 
on treatment outcome with Y-BOCS post-treatment score as the dependent variable.  
Missing data. Seventy-eight patients were screened for inclusion. Two patients 
were excluded after initial screening because OCD was not the primary diagnosis. The 
total sample in the present analysis thus consisted of 76 patients. Five patients with 
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missing data on the B-IPQ were included in the descriptive statistics, but where 
excluded from further analyses.  
Twenty-four patients had missing data on the B-IPQ post treatment. Independent 
t-tests were conducted in order to reveal significant biases in the missing data between 
the OCD patients with and without the B-IPQ post data. There were no significant 
differences between the two groups regarding pre-treatment OCD severity (Y-BOCS) 
t(69) = 0.06, p = 0.95, BDI t(66) = 0.10, p = 0.91, OCD duration t(57) = -0.16, p = 0.87, 
comorbidity t(69) = 0.23, p = 0.81, gender t(69) = -0.05, p = 0.95, age t(69) = 0.021, p = 
0.98, previous treatment t(64) = 0.36, p = 0.72, or use of SSRI t(67) = -0.68, p = 0.49.  
Ethics 
The present study is a part of a standard quality control performed at the 
outpatient OCD-clinic at Haukeland University Hospital in Bergen, Norway, consented 
by the Personvernombudet 08.05.2012.  
Results 
Pre-treatment illness perception in OCD  
Comparison of pre-treatment descriptive statistics of illness perception in OCD-
patients, BD and RA are presented in Table 1. The OCD patients had a total B-IPQ 
score of 52.59 (SD = 8.54, scores 3, 4 and 7 were reversed), which indicate an on 
average high score compared to the possible maximum total score of 80. Total B-IPQ 
scores were not available for the reference samples. On the dimension consequences the 
OCD patients had a mean score of (M = 8.08, SD = 1.70), which indicate that the OCD 
patients perceived their illness as having significantly more negative consequences 
compared to patients with RA t(169) = 10.38, p < .000, while there were no significant 
differences compared to patients with BD.  
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On the dimension timeline the OCD-sample had a mean score of (M = 7.73, SD 
= 1.89), which indicate that the OCD patients perceived their illness to last longer 
compared to patients with RA t(169) = 8.91, p < .000, while there were no significant 
differences between the OCD patients and the patients with BD regarding this 
dimension. On the dimension personal control the OCD patients had a mean score of 
(M = 3.34, SD = 1.98), which indicate that the OCD patients perceived significantly 
lower personal control related to their condition compared to the patients with BD 
t(158) = 3.52, p < .000, as well as patients with RA t(169) = 6.21, p < .000. On the 
dimension treatment control the OCD patients had a mean score of (M = 7.47, SD = 
2.19), which indicate that the OCD patients perceived treatment as more helpful 
compared to patients with RA t(169) = 2.63, p = .009, while there were no significant 
differences between the OCD patients and patients with BD regarding this dimension. 
On the dimension identity the OCD patients had a mean score of (M = 7.16, SD = 2.07), 
which indicate that the OCD patients perceived to have more symptoms related to their 
condition compared to patients with RA t(169) = 6.26, p < .000, while there were no 
significant differences between the OCD patients and the patients with BD regarding 
this dimension. On the dimension concern the OCD patients had a mean score of (M = 
7.94, SD = 2.06), which indicate that the OCD patients were significantly more 
concerned about their illness compared to the patients with BD t(160) = 3.02, p = .0029, 
as well as patients with RA t(169) = 8.41, p < .000. On the dimension coherence the 
OCD patients had a mean score of (M = 6.17, SD = 2.66), which indicate that the OCD 
patients had less understanding of their illness compared to patients with BD t(160) = 
2.13, p = .034, but a higher understanding of their illness compared to patients with RA 
t(169) = 2.67, p = .008. Also, on the dimension emotional representations the OCD 
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patients had a mean score of (M = 8.49, SD = 1.46), which indicate that the OCD 
patients perceived their OCD as having substantially more negative emotional impact 
on their lives compared to patients with RA t(169) = 10.45, p < .000, while there were 
no significant differences between the OCD patients and the patients with BD regarding 
this dimension.  
 
(Insert Table 1 here) 
 
 
Variables related to pre-treatment illness perception 
Correlational analysis. An explorative correlational analysis was conducted to 
investigate the relationships between the dimensions in the B-IPQ, OCD-severity pre-
treatment (Y-BOCS total score), BDI, OCD duration, comorbidity, age, gender, use of 
SSRI, and previous treatment. Illness perception correlated significantly with Y-BOCS 
on several of the B-IPQ dimensions: consequences (r = 0.50, p < .001), timeline (r = 
0.27, p < .05), personal control (r = -0.46, p < .001), identity (r = 0.32, p < .01), 
emotional representations (r = 0.45, p < 0.001) and the B-IPQ total score (r = 0.44, p < 
.01). Illness perception correlated significantly with BDI on the B-IPQ dimensions: 
consequences (r = 0.26, p < 0.05), personal control (r = -0.26, p < .05), concern (r 0.25, 
= p < .05), emotional representations (r = 0.36, p < .01), and the B-IPQ total score (r = 
0.33, p < .01). The B-IPQ dimension timeline correlated significantly with OCD 
duration (r = 0.32, p < .05). The B-IPQ dimension identity correlated significantly with 
age (r = 0.26, p < .05), as well as there were significant correlations between the 
dimension personal control and comorbidity (r = -0.28, p < .05), and the B-IPQ total 
score and comorbidity (r = 0.28, p < .05). Gender, previous treatment and use of SSRI 
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did not significantly correlate with any variables, and were therefore excluded from 
further analyses. A summary of these correlations are shown in Table 2. 
  
(Insert Table 2 here) 
 
 
Regression analyses. To investigate which variables that could account for 
systematic variance in pre-treatment illness perception, a number of analogous stepwise 
multiple regression analyses were conducted with the B-IPQ total score or each of the 
B-IPQ dimensions as dependent variables. Based on the explorative correlational 
analysis (see Table 2) the variables OCD severity (Y-BOCS total score pre-treatment), 
OCD duration, symptoms of depression (BDI), comorbidity, and age were selected as 
the predictor variables in each of the following analyses.  
The B-IPQ total score as the dependent variable and the above described 
predictors: Pre-treatment OCD severity explained 18 % of the variance in illness 
perception (F1, 55 = 12.32,  p < .01). The remaining variables did not explain additional 
variance, and were not entered. 
Consequences as the dependent variable and the above described predictors:  
Pre-treatment OCD severity pre-treatment was entered in step one and contributed to 
the explanation of 26 % of the variance regarding perceived consequences (F1, 55 = 
20.05,  p < .001). 
Duration as the dependent variable and the above described predictors: Pre-
treatment OCD duration was entered in step one and explained 9% of the variance in 
perceived timeline (F1, 55 = 5.61, p < .05). 
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Personal control as the dependent variable and the above described predictors: 
Pre-treatment OCD severity pre-treatment were entered in step one and explained 16 % 
of the variance regarding personal control (F1, 55 = 10.99, p < .01).  
Identity as the dependent variable and the above described predictors: Pre-
treatment OCD severity pre-treatment was entered in step one and explained 10 % of 
the variance regarding identity (F1, 55 = 6.70, p < .05). Age was entered in the second 
step and added another 7 % of the variance in the model (F2, 54 = 5.66, p < .05).  
Emotional representations as the dependent variable and the above described 
predictors: Pre-treatment OCD severity pre-treatment was entered in step one and 
explained 24 % of the variance regarding emotional representations (F1, 55 = 18.02, p 
< .001). BDI was entered in step one and added another 8 % of the variance in the 
model (F2, 54 = 12.24, p < .05).  
Treatment control, concern and coherence as the dependent variable and the 
above described predictors: None of the predictors contributed significantly to 
explained variance in the dimensions treatment control, concern and coherence. A 
summary of the stepwise multiple regression analyses are shown in Table 3. 
 
 (Insert Table 3 here) 
 
 
Changes in illness perception from pre- to post-treatment 
Paired t-tests were used to compare changes in each of the illness perception 
dimensions from pre-to post-treatment. There were significant reduction in the 
dimension consequences from pre- to post-treatment t(46) = 14.29, p < .000, (M = 3.45, 
SD = 1.81), which indicate that the OCD had less impact on the patients` life after the 
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group-intervention. Significant reduction in the perceived timeline t(46) = 9.35, p < 
.000, (M = 3.79, SD = 2.39), indicates that the OCD patients did not perceive their 
illness to last as long as they did before the treatment. Significant increase in perceived 
personal control t(46) = -8.91, p < .000, (M = 6.79, SD = 2.07), indicate that the OCD 
patients had more positive perceptions regarding their own personal influence on their 
OCD after the intervention. There were also significant increase regarding treatment 
control t(42) = -2.60, p < .013, (M = 8.28, SD = 1.62), which indicate that the OCD 
patients had more positive perceptions about treatment as helpful. Significant reduction 
regarding the dimension identity t(45) = 7.29, p < .000, (M = 4.28, SD = 1.89), indicate 
that the patients perceive fewer symptoms related to their OCD after the intervention. 
There were significant reduction in perceived concern t(46) = 8.98, p < .000, (M = 3.94, 
SD = 2.17), which indicate that the OCD patients had less negative perceptions 
regarding concern about their OCD after the treatment. A significant increase in 
perceived coherence t(46) = -6.50, p < .000, (M =  8.38, SD = 1.40) after treatment, 
indicate that the OCD patients gained a higher understanding for their illness. 
Significant reduction in emotional representations t(46) = 9.11, p < .000, (M = 5.00, SD 
= 2.35), indicate that the OCD patients perceived their OCD as having less emotional 
impact after the treatment. The significant reduction in the B-IPQ total scores from pre- 
and post-treatment t(46) = 12.73, p < .000, (M = 6.91, SD = 11.74, scores on items 3, 4 
and 7 were reversed), indicate an overall change where illness perceptions have less 
negative impact following treatment.  
Pre-treatment illness perception as predictor of post-treatment OCD severity 
To investigate potential variables that could predict OCD severity following 
treatment, two stepwise multiple regression analyses were conducted with the Y-BOCS 
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total post-scores as the dependent variable. The purpose of the first analyses was to 
determine whether variables reported as predictors in previous research also explained 
variance in treatment-outcome in the current sample. Pre-treatment OCD severity and 
pre-treatment B-IPQ total score were highly correlated, and we decided therefore not to 
include these two variables simultaneously in the first analysis. In the first analysis we 
selected variables which have been suggested as treatment predictors by previous 
research (Öst et al. 2015, Olatunji et al. 2013, Rosa-Alcázar et al. 2008), and the 
predictor variables were thus symptoms of depression (BDI), age, comorbidity, duration 
of OCD and Y-BOCS-rated OCD severity. None of the predictor variables entered in 
the analysis, which indicated that none of the variables contributed to the explanation of 
the treatment outcome. In the second analysis we selected the B-IPQ total score as well 
as each of the B-IPQ subscales as predictors. The results showed that the dimension 
coherence explained 6 % of the variance of OCD severity post-treatment measured by 
Y-BOCS (F1, 63 = 4.16, p < 0.05). The remaining variables were not entered into the 
equation and were therefore excluded.  
Discussion 
The aims of the present study were to assess illness perception in a sample of 
OCD patients prior to and after a 4-day ERP-based group intervention, and to determine 
to what extent illness perception was related to treatment outcome. We found that OCD 
patients expressed significantly equal as well as more severe degrees of illness 
perception compared to two reference populations. This is an interesting finding, given 
that OCD is ranked by the WHO as one of the ten most debilitating disorders with a 
chronic course. The main finding of the present study was that the B-IPQ dimension 
coherence was the only variable emerging as a significant predictor of treatment 
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outcome. Our study did not show empirical support for the predictors gender, previous 
treatment, and the use of SSRI, which have been identified by previous research to 
influence treatment outcome (Öst et al. 2015, Olatunji et al. 2013, Rosa-Alcázar et al. 
2008).  
The OCD patients perceived their illness as severe with substantial 
consequences and negative emotional impact as well as reduced personal control and a 
long illness timeline. They also perceived having many symptoms and significant 
concern about their illness. The only dimension with a more positive perception was 
treatment control, where the OCD patients perceived treatment to be more helpful 
compared to the reference-sample RA. Since the OCD-sample consists of treatment 
seeking patients, this finding can be expected.  
The main differences between the patients with OCD and the reference-samples 
were that the OCD patients were more concerned about their illness, and they perceived 
having lower personal control. Another finding was that the OCD patients perceived 
their illness to last longer compared to patients with RA, and they had similar 
perception of illness timeline as patients with BD. This is interesting due to the 
chronicity of both RA and BD which also is a relevant aspect of OCD if untreated, 
though OCD is highly treatable for the majority of patients (Öst et al 2015). The OCD-
patients also perceived their illness to have substantially more negative impact on their 
lives, both emotionally and related to illness consequences, compared to patients with 
RA. This is in line with literature commonly reporting that OCD patients have 
substantially reduced quality of life as a result of their illness (Abramowitz 1997). The 
OCD patients perceived similar illness severity compared to patients with BD regarding 
consequences, treatment control, identity, and emotional representations
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is interesting considering the chronicity of BD compared to the possibilities of recovery 
for OCD patients.  
Pre-treatment OCD severity was the only significant predictor of pre-treatment 
illness perception, specifically the OCD severity was related to perceived consequences, 
personal control and emotional representations. The duration of the OCD also 
explained some of the perceived illness timeline. This is interesting, especially since the 
variables BDI, age, and comorbidity did not explain any of the variance in pre-treatment 
illness perception. In sum, these findings makes sense, since illness perception is 
expected to be closely related to disorder-specific symptoms, and thus confirms the B-
IPQ as a disorder-sensitive questionnaire. Previous studies have specifically identified 
personal control as a dimension of importance, where increased perceived control have 
been associated with a positive treatment outcome (Baines and Wittkowski 2013). 
However, the dimension personal control did not influence treatment outcome in the 
present study.  
The 4-day ERP-intervention was highly effective, and it is important to note that 
despite the patients’ negative illness perceptions, these perceptions did not prevent the 
patients from gaining substantially from the treatment. Overall the results indicate that 
even severely negative pre-treatment illness perception, did neither prevent the 
treatment effect or treatment adherence. A total of 64 patients in the OCD-sample were 
categorized as having clinical significant change, where 77 % were classified as 
recovered and 9.5 % as improved (Havnen et al. 2014, Havnen et al. 2015). The 
recovery percentage was a somewhat larger proportion compared to previous studies on 
ERP (Fisher and Wells 2005). 
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As expected, the illness perception in the OCD-sample changed significantly 
from pre- to post treatment on all dimensions. Again, this supports the B-IPQ as a 
disorder-specific instrument sensitive for relatively rapid changes in symptoms. The 
literature also indicates that patients` illness perceptions are part of a dynamic process, 
where symptom reduction or psychoeducational aspects, like new information about the 
illness, may lead to re-evaluations of the perceptions of illness (Petrie et al. 2008), and 
influence treatment outcome.  
One of the main findings in the current study was that the OCD patients gained a 
significantly higher understanding (coherence) of their illness post-treatment. Based on 
the current design, we do however not know whether this change occurred after the 
initial psychoeducation, or after the therapist-assisted ERP.  In order to address 
temporal changes in illness perception and their possible relationship with treatment 
outcome, patients might be randomized to either receive the psychoeducation e.g. 
minimum two weeks prior to ERP-treatment or immediately before like in the current 
study, and changes in both illness perception and OCD symptoms measured in parallel 
pre, during and post the interventions. In future studies it would also be of interest to 
investigate whether illness perception would be predictive of relapse in OCD-patients. 
There are results in other illnesses indicating such influence, as in bipolar disorder 
where illness perception did contribute to the prediction of time to relapse (Lobban et al. 
2013).Whether illness perception contribute to the explanation of relapse in OCD 
patients could be investigated by measuring illness perception and OCD symptoms e.g. 
six months as well as one year after the treatment. The information about temporal 
changes in illness perception and illness perception as predictor of relapse might be of 
clinical relevance, especially in a stepped-care perspective regarding the optimization of 
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individually tailored treatment (Gilliam et al. 2010). Individually adjusted treatment is 
also in previous literature argued to be of importance for treatment acceptance, response 
and outcome (Williams and Steer 2011, Weinman and Petrie 1997). 
A possible limitation of the current study is related to the limited number of 
reference-groups available for comparison. Most of the studies on illness perception 
have studied somatic populations with little research on mental health. In addition the 
majority of the literature on illness perception has applied the IPQ, the IPQ-R or 
adjusted versions of the B-IPQ, which makes comparison more difficult.  
In conclusion, the present study is the first to show that illness perception is a 
useful model assessing OCD patients` perspectives of their disorder and symptoms, but 
also of interest exploring the individuality within the perceptual dimensions. The 4-day 
intervention employed in the current study is considered a good model for investigating 
potential predictors for treatment outcome, such as illness perception. The reason for 
this is the concentrated format which can be considered close to a controlled, 
experimental intervention with all active treatment components delivered during four 
consecutive days. However, it would have been more feasible if illness perception also 
were measured immediately after the psychoeducation. Applying the 4-day intervention 
in this study showed that illness perception contributed to the explanation of treatment 
outcome only by the dimension coherence. At the same time, the pre-treatment negative 
illness perceptions did not influence treatment adherence or recovery. 
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Table 1. Mean scores B-IPQ of OCD sample and comparisons with BD and RA 
 OCD  BD  RA  
Dimensions N=71  N=88-91  N=100  
 M (SD) Range M (SD) Range       M (SD) Range 
Consequences 8.11 (1.72) 3-10 7.38 (2.76) 1-10 4.83 (2.23) 1-10 
Timeline 7.73 (1.89) 2-10 7.27 (2.98) 1-10 5.05 (1.94) 2-10 
Personal control 3.34 (1.98) 0-9 4.69 (2.70) 1-10 5.08 (1.67) 1-9 
Treatment control 7.47 (2.19) 2-10 7.44 (2.37) 1-10 6.62 (1.99) 0-10 
Identity 7.16 (2.07) 1-10 7.01 (2.51) 1-10 5.17 (2.03) 1-9 
Concern 7.94 (2.06) 1-10 6.71 (2.90) 1-10 5.22 (2.1) 1-10 
Coherence 6.17 (2.66) 1-10 7.08 (2.72) 1-10 5.1 (2.52) 0-10 
Emotional repr. 8.49 (1.46) 4-10 8.44 (2.03) 1-10 5.33 (2.23) 1-10 
 
Note. OCD = Obsessive-Compulsive Disorder; BD = bipolar disorder (Lobban et al. 
2003); RA = rheumatoid arthritis (Rezaei et al. 2014); Emotional repr. = Emotional 
representations; M = mean; SD = standard deviation. 	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Table 2. Intercorrelations between pre-treatment illness perception and clinical aspects  
Dimensions B-IPQ Y-BOCS BDI Duration Comorbidity Age 
Consequences 0.51a 0.26b 0.19 0.08 0.05 
Timeline 0.27b 0.13 0.32b 0.24 -0.01 
Personal control -0.46a -0.26b -0.00 -0.28b 0.01 
Treatment control 0.08 -0.15 0.05 -0.23 0.04 
Identity 0.32a 0.16 0.23 -0.01 0.26b 
Concern 0.20 0.25b 0.12 0.18 0.13 
Coherence 0.01 0.03 0.18 -0.05 0.02 
Emotional representations 0.45a 0.36a 0.05 0.21 -0.09 
The B-IPQ total score 0.44a 0.33a 0.15 0.28b 0.06 
 
Note.Y-BOCS = Yale-Brown Obsessive-Compulsive Scale, BDI = Becks Depression 
Inventory, Duration = OCD-duration. Significant variables are highlighted. 
a p  < 0.01, two-tailed, b p < 0.05, two-tailed. 
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Table 3. Stepwise multiple regression of predictors of pre-treatment illness perception  
 Multiple R B SE B Beta t 
B-IPQ total score      
Step 1      
Y-BOCS pre 0.42 0.88 0.25 0.42 3.51b 
Consequences      
Step 1      
Y-BOCS pre 0.51 0.22 0.05 0.51 4.51c 
OCD-duration      
Step 1      
OCD-duration  0.30 0.05 0.02 0.30 2.36a 
Personal control      
Step 1      
Y-BOCS pre 0.40 -0.18 0.05 -0.40 -3.31b 
Identity      
Step 1      
Y-BOCS pre 0.33 0.18 0.06 0.35 2.83a 
Step 2      
Age 0.41 0.05 0.02 0.25 2.05a 
Emotional representations      
Step 1      
Y-BOCS pre 0.49 0.15 0.04 0.43 3.74c 
Step 2 
BDI 
  
0.55 
 
0.04 
 
0.02 
 
0.26 
 
2.26a 
 
Note. Y-BOCS = Yale-Brown Obsessive-Compulsive Scale; B-IPQ = Brief Illness 
Perception Questionnaire; SE B = standard error B. Only significant predictors were 
entered in the analysis. 
a p < 0.05, two-tailed, b p  < 0.01, two-tailed,  cp < 0.001, two-tailed. 
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Appendix 1 
BIPQ  
 
Vennligst sett en ring rundt det tallet som best samsvarer med din mening om de følgende spørsmålene.  
	  
Hvor	  mye	  påvirker	  sykdommen	  livet	  ditt?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Ingen            Voldsom 
påvirkning            påvirkning  
	  
Hvor	  lenge	  tror	  du	  at	  sykdommen	  din	  vil	  vare?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Svært kort tid           For alltid
            
Hvor	  mye	  kontroll	  føler	  du	  at	  du	  har	  over	  sykdommen	  din?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Absolutt ingen          Svært stor 
kontroll             kontroll
            
Hvor	  mye	  mener	  du	  at	  behandlingen	  din	  kan	  hjelpe	  mot	  sykdommen	  din?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Ikke i det          Svært hjelpsom 
hele tatt  
	  
Hvor	  mye	  opplever	  du	  symptomer	  fra	  sykdommen	  din?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Ingen symptomer                       Mange alvorlig 
i det hele tatt                 symptomer 
	  
Hvor	  bekymret	  er	  du	  angående	  sykdommen	  din?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Ikke bekymret          Svært bekymret 
i det hele tatt  
	  
Hvor	  godt	  føler	  du	  at	  du	  forstår	  sykdommen	  din?	   
 
0  1  2  3  4  5  6  7  8  9  10 
Forstår ikke          Forstår svært  
i  det hele tatt         godt 
	  
Hvor	  mye	  påvirker	  sykdommen	  din	  deg	  følelsesmessig?	  (dvs	  gjør	  den	  deg	  sint,	  redd,	  urolig	  
eller	  deprimert?)	   
 
0  1  2  3  4  5  6  7  8  9  10 
Ikke påvirket           Svært påvirket 
følelsesmessig           følelsesmessig 
i det hele tatt           	  
	  
Vennligst	  skriv	  ned	  i	  rekkefølge	  de	  tre	  viktigste	  faktorene	  som	  du	  tror	  forårsaket	  
sykdommen	  din.	  De	  aller	  viktigste	  årsaker	  for	  meg:	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1. ____________________________________________________ 2. 
____________________________________________________ 3. 
____________________________________________________  
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